RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Pivotal bioVenture Partners Investment Advisor LLC's Holding History (CIK: 0001844645)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 595,518 Value ($000) $2,436 Avg Close $4.95 Range $3.81 - $7.18

Q3 2025

Shares 595,518 Value ($000) $2,906 Avg Close $5.25 Range $4.45 - $7.15

Q2 2025

Shares 595,518 Value ($000) $3,013 Avg Close $4.91 Range $3.79 - $6.11

Q1 2025

Shares 595,518 Value ($000) $3,150 Avg Close $7.29 Range $5.19 - $12.36

Q4 2024

Shares 595,518 Value ($000) $4,026 Avg Close $6.72 Range $5.60 - $9.55

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	595,518	$2,436	$4.95	$3.81 - $7.18
Q3 2025	595,518	$2,906	$5.25	$4.45 - $7.15
Q2 2025	595,518	$3,013	$4.91	$3.79 - $6.11
Q1 2025	595,518	$3,150	$7.29	$5.19 - $12.36
Q4 2024	595,518	$4,026	$6.72	$5.60 - $9.55